# Encompass Health Corp > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Encompass Health Corp). ## Overview Encompass Health Corp owns and operates inpatient rehabilitation hospitals that treat patients recovering from major injury or illness and needing intensive therapy to regain function and independence. It is the largest U.S. operator in this niche by patients treated, revenue, and hospital count, with a network spanning 39 states and Puerto Rico. ## Products & services • Inpatient rehabilitation hospital services • Intensive therapy and post-acute rehab care • Patient care for stroke, trauma, and complex recovery • State supplemental payments and other non-patient revenue • Hospital development through de novo builds and bed additions - **Inpatient rehabilitation hospital services** (90%) — Specialized inpatient care and therapy for patients recovering from major injury or illness. - **Non-patient care revenue** (10%) — State directed and supplemental payments plus management and administrative fees. - Inpatient rehabilitation hospital services - Intensive therapy and post-acute rehab care - Patient care for stroke, trauma, and complex recovery - State supplemental payments and other non-patient revenue - Hospital development through de novo builds and bed additions ## Customers The company serves patients referred after acute-care hospitalization who need intensive rehabilitation before returning home or to a lower level of care. Its economic buyers are primarily Medicare, Medicare Advantage, Medicaid, commercial payors, and other third-party payors that reimburse the care, while referrals come from hospitals, physicians, and case managers. Growth depends on maintaining access to these referral sources and demonstrating better outcomes and cost-effective care. - **Patient referrals from acute-care hospitals** (primary) — Hospitals discharge patients needing intensive rehab; this is the main source of admissions and is strategically critical. - **Medicare and Medicare Advantage beneficiaries** (primary) — Older and medically complex patients whose reimbursement drives a large share of operating revenue. - **Commercial and managed care payors** (secondary) — Insured patients whose contracts and utilization rules affect pricing and admission flow. - **Medicaid patients and state programs** (secondary) — Patients covered by Medicaid, including supplemental payment programs that support revenue. - **Physicians, case managers, and referral networks** (primary) — Influence patient placement decisions and determine access to admissions in local markets. - Patients recovering from stroke, trauma, surgery, or severe illness - Acute-care hospitals that refer patients into post-acute rehab - Physicians and case managers who influence discharge placement - Medicare and Medicare Advantage patients, a major payer base - Medicaid and commercial payors that reimburse inpatient rehab ## Geography Encompass Health operates across 39 states and Puerto Rico, with especially heavy concentration in Florida and Texas. Its footprint is built around local referral relationships and certificate-of-need markets, so geography directly affects admissions, competitive intensity, and expansion opportunities. The company continues to add beds and open de novo hospitals in growth markets such as Florida, Texas, Pennsylvania, Arizona, and the Southeast. - **United States** (100%) — The company operates in 39 states; no country-level revenue split was disclosed. - **Puerto Rico** (0%) — Operating presence disclosed, but no separate revenue share provided. - Operations span 39 states and Puerto Rico - Florida and Texas are the largest concentration markets - Local referral density drives admissions and utilization - Certificate-of-need states can limit new competition - De novo growth targets Sun Belt and other high-demand markets ## Strategy The company is expanding capacity through de novo hospitals, joint ventures, remote and satellite hospitals, and bed additions while preserving a flexible balance sheet. Management is positioning the business to benefit from coordinated care and payment models by emphasizing high-quality outcomes, cost-effective care, and strong referral relationships. Real estate ownership and limited near-term debt maturities support continued growth and adaptation to reimbursement changes. - **De novo hospital expansion and bed additions** (medium-term) — Adds capacity in markets with strong demand and supports long-term volume growth. - **Referral-source relationship management** (short-term) — Admissions depend heavily on acute-care hospital and physician referrals. - **Operational quality and cost efficiency** (medium-term) — Better outcomes and lower cost per episode strengthen payer and referral acceptance. - **Balance sheet flexibility** (short-term) — Supports growth and cushions reimbursement or regulatory volatility. - Open new hospitals and add beds in high-demand markets - Use joint ventures to expand selectively and share risk - Protect referral relationships with acute-care hospitals - Maintain cost-effective care and strong patient outcomes - Keep balance sheet flexibility for reimbursement changes ## Risks The biggest risk is reimbursement pressure, especially from Medicare, Medicaid, and managed care, because the company’s revenue depends on regulated payment rates and complex billing rules. It also faces referral concentration risk since most admissions come from acute-care hospitals, plus execution risk from acquisitions, joint ventures, and new hospital development. As a healthcare operator, it is exposed to compliance, cybersecurity, and Medicare participation risks that can disrupt operations or trigger penalties. - **Reimbursement reductions or rule changes** [high] — A large share of revenue comes from Medicare and other regulated payors. - **Referral-source concentration** [high] — About 92% of admissions come from acute-care hospitals, so referral shifts can quickly affect volumes. - **Competitive pressure in local markets** [medium] — Other post-acute providers and acute-care systems can expand rehab offerings and compete for patients. - **Acquisition and joint venture execution** [medium] — Growth strategy relies on transactions that can face approvals, integration issues, and hidden liabilities. - **Regulatory and Medicare compliance** [high] — Failure to meet conditions of participation or anti-kickback rules could disrupt operations. - Government reimbursement changes can reduce revenue and margins - Admissions depend on acute-care referral sources and discharge patterns - Competition from hospitals, nursing homes, and post-acute providers is intense - New ventures and acquisitions can create integration and regulatory risks - Healthcare compliance failures can threaten Medicare participation ## Accounting Revenue is recognized when services are performed, but the company must estimate transaction price using contractual allowances, payment reviews, and uncollectible amounts, which makes revenue sensitive to payer mix and settlement assumptions. Supplemental Medicaid payments and provider taxes can also create timing and presentation noise in outpatient and other revenue. Investors should also watch impairment, depreciation, and stock-based compensation, which are meaningful non-cash items in reported earnings and Adjusted EBITDA reconciliation. - **Revenue recognition estimates** — Affects reported revenue, receivables, and margin timing - **Medicare and Medicaid reimbursement settlements** — Can change revenue and other income across periods - **Supplemental payments and provider taxes** — Affects operating revenue mix and expense comparability - **Asset depreciation and impairment** — Influences operating profit and non-cash charges - Revenue estimates depend on contractual allowances and payer mix - Medicare and Medicaid reviews can change recognized revenue later - Supplemental payments and provider taxes affect other revenue and expenses - Depreciation, amortization, and asset impairments are material non-cash items - Adjusted EBITDA adds back stock compensation and other non-cash charges --- *Last updated: 2026-04-28T20:04:52.964586+00:00*